Company / Return on Assets (ROA)
Protara Therapeutics, Inc. Return on Assets (ROA) History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-7.7%
FY2016
5-year range
-11.7% / -7.7%
FY2014-FY2016
Trend
+34.4%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -9.4% to -7.7% over the past 2 years.
Based on SEC 10-K filings.
-7.7% in FY2016.
Improved from -9.4% to -7.7% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, return on assets (roa) increased 34.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2016 | -7.7% | +34.4% |
| FY2015 | -11.7% | -24.6% |
| FY2014 | -9.4% | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026